MADISON PETERSON: Open Payments
NPI 1407362692 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 41 payments from 8 companies in 2025. Trend: 2023 $840 · 2024 $385 · 2025 $1,068
Food & beverage: $970Education: $98
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $419 |
| Amgen Inc. | 18 | $212 |
| Janssen Biotech, Inc. | 6 | $189 |
| Regeneron Healthcare Solutions, Inc. | 3 | $135 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Incyte Corporation | 1 | $27 |
| UCB, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: DUPIXENT, OTEZLA, TREMFYA, COSENTYX, OPZELURA, Bimzelx, Sotyktu.
Industry payments across CA — which companies pay providers there.
